Table 2.
The numbers of neurologists, treatment centers, and patients included in the main study
| Treatment centers with drug program B.29 (n = 18) | Treatment centers with drug programs B.29 and B.46 (n = 27) | Total | |
|---|---|---|---|
| Neurologists | 21 | 27 | 48 |
| Patients with active RRMS | 277 | 364 | 641 |
| Patients with active RRMS currently or previously treated within the B.29 drug program who did not meet the Polish drug program criteria but met the Polish Neurological Society criteria for second-line treatment | 70 |
69 |
139 |
n – number, RRMS – relapsing-remitting multiple sclerosis